Samjin Pharmaceutical and Korea Pharma have launched first generics in Korea. Samjin Pharmaceutical will launch the first generic of Sanofi's atrial fibrillation drug Multaq Tab, while Korea Pharma will launch the first generic of Pfizer's antidepressant Pristiq ER Tab.

According to industry sources, Samjin Pharmaceutical's ‘Samjin Dron Tab
as (dronedarone)’ will be listed at KRW 808 per tablet in Korea.

The drug is indicated for the management of atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF to reduce the risk of hospitalization.

Adults may take 1 tablet (dronedarone 400 mg) twice daily with breakfast and din